Evidence map›Paper›PMID 32458402›Full record

ArticleJournal of cardiovascular translational research2020

Trends in the Use of Cardiac Imaging for Women with Newly Diagnosed Breast Cancer.

Ana Barac, Claudine Isaacs, Nawar M Shara, Filipa Lynce, Sameer Desale, Kevin Haynes, Arnold L Potosky

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Cardio-Oncology in 2020: Prime for Translation.Journal of cardiovascular translational research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana BaracMedStar Heart and Vascular Institute, Georgetown University, 110 Irving Street, NW, Ste. 1218, Washington, DC, 20010, USA. Ana.Barac@medstar.net.ORCID 0000-0002-9935-8904
Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Nawar M SharaDepartment of Biostatistics and Biomedical Informatics, MedStar Health Research Institute, Hyattsville, MD, USA.
Filipa LynceLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Sameer DesaleDepartment of Biostatistics and Biomedical Informatics, MedStar Health Research Institute, Hyattsville, MD, USA.
Kevin HaynesHealthCore, Inc., Wilmington, DE, USA.
Arnold L PotoskyLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

Funding

Impact of Genomic and Personalized Medicine in Women under 65 with Breast Cancer - SupplementR01CA160671 · NCI · GEORGETOWN UNIVERSITY · PI POTOSKY, ARNOLD L · 2012 to 2016
$1.0M
National Institutes of Health (US) P30CA051008NIH HHS R01CA160671
6 · The paper itself

Abstract

We investigated time trends and factors associated with the use of cardiac imaging among women with early-stage breast cancer prior to the initiation of treatment. Of 11,732 women ages 24-64, diagnosed with stage I-III breast cancer in 2006-2011, 2550 (22%) received anthracycline-based chemotherapy. Baseline cardiac imaging was used in 79% of patients receiving anthracyclines and increased over time. Of 2277 (20%) women who received non-anthracycline therapy, 16% received cardiac imaging. Women receiving cardiac imaging in non-anthracycline therapy group were more likely to have higher cardiovascular risk, as well as higher cancer stage and worse histological tumor grade suggesting that results of imaging might have influenced the choice of cancer therapy. Our findings indicate the need for cardio-oncology collaboration in identification and treatment of women at high risk for adverse oncology and cardiovascular outcomes.

Indexed as

Cardiac Imaging TechniquesAdultAnthracyclinesAntibiotics, AntineoplasticBreast NeoplasmsCardiotoxicityChemotherapy, AdjuvantDatabases, FactualEarly DiagnosisFemaleHeart DiseasesHumansMiddle AgedNeoplasm StagingPredictive Value of TestsRegistriesAnthracyclinesAntibiotics, AntineoplasticAdverse eventsBiological therapyBreast cancerCardiotoxicityCardiovascular diseaseCardiovascular imagingChemotherapyDiagnostic imaging

Identifiers

PMID32458402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.